Karyopharm Therapeutics Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2016-12-31 was 17.09K shares, a 14.62% decline year-over-year.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2016-09-30 was 0.00 shares.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2015-12-31 was 20.02K shares, a 222.77% increase year-over-year.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2015-09-30 was 0.00 shares.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 46.81K shares, a 84.16% increase from fiscal 2015.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2015 was 25.42K shares, a 309.88% increase from fiscal 2014.
- Karyopharm Therapeutics Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2014 was 6.20K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2016-12-31 | 17.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 46.81K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | |
| 2015-12-31 | 20.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 25.42K shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | |
| 2014-12-31 | 6.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 6.20K shares 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |